For depression and/or anxiety. ANDA 70791, held by Mylan Pharms Inc. Doxepin Hydrochloride.
As of Nov 16, 2026, ANDA 70791 (Doxepin Hydrochloride), held by Mylan Pharms Inc, was first approved by FDA on May 13, 1986, with 17 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Doxepin Hydrochloride Capsules, USP are recommended for the treatment of: 1. Psychoneurotic patients with depression and/or anxiety. 2. Depression and/or anxiety associated with alcoholism (not to be taken concomitantly with alcohol). 3. Depression and/or anxiety associated with organic disease (the possibility of drug interaction should be considered if the patient is receiving other drugs concomitantly). 4. Psychotic depressive disorders with associated anxiety including involutional depression and manic-depressive disorders.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 13, 1986 | Original application | Approved | None posted |
| Doxepin HydrochlorideEQ 50MG BASE · capsule;oral | Doxepin Hydrochloride | Rx |
| Doxepin HydrochlorideEQ 10MG BASE · capsule;oral | Doxepin Hydrochloride | Rx |
| Doxepin HydrochlorideEQ 25MG BASE · capsule;oral | Doxepin Hydrochloride | Rx |
| Doxepin HydrochlorideEQ 75MG BASE · capsule;oral | Doxepin Hydrochloride | Rx |
| Doxepin HydrochlorideEQ 100MG BASE · capsule;oral | Doxepin Hydrochloride | Rx |
| Jul 16, 2026 | Supplement 40Labeling · Standard review | Approved | None posted |
| May 29, 2015 | Supplement 28Labeling · Standard review | Approved | None posted |
| Jul 17, 2014 | Supplement 27Labeling · Standard review | Approved | |
| Apr 17, 2008 | Supplement 19Labeling | Approved | None posted |
| Jul 11, 2007 | Supplement 18Labeling | Approved | None posted |
| Nov 14, 2005 | Supplement 17Labeling | Approved | None posted |
| Jul 8, 2005 | Supplement 15Labeling | Approved | None posted |
| Jul 8, 2005 | Supplement 16Labeling | Approved | None posted |
| Oct 25, 2000 | Supplement 12Labeling | Approved | None posted |
| Feb 25, 1998 | Supplement 11Manufacturing | Approved | None posted |
| Feb 5, 1998 | Supplement 10Manufacturing | Approved | None posted |
| Jul 5, 1995 | Supplement 9Labeling | Approved | None posted |
| Nov 19, 1993 | Supplement 8Manufacturing | Approved | None posted |
| Jun 30, 1993 | Supplement 7Labeling | Approved | None posted |
| Jul 11, 1989 | Supplement 3Manufacturing | Approved | None posted |
| Jun 22, 1989 | Supplement 5Labeling | Approved | None posted |
| Oct 28, 1986 | Supplement 1Manufacturing | Approved | None posted |
| May 13, 1986 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters